CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464097528
- Phone
- 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $89,088
- in 5 filings, $89K under 10b5-1 plans
Net −$89,088. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 4 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-07-18 | Myer Vickesh Chief Technology Officer | Option exercise | +850 | $11.21 | $10K | 850 |
| 2018-07-18 | Myer Vickesh Chief Technology Officer | Sale | −850 | $36.25 | $31K | 0 |
| 2018-07-18 | Myer Vickesh Chief Technology Officer | Option exercise · Stock Option (right to buy) | −7,000 | 76,897 | ||
| 2018-07-17 | Myer Vickesh Chief Technology Officer | Option exercise | +3,000 | $0.65 | $2K | 3,000 |
| 2018-07-17 | Myer Vickesh Chief Technology Officer | Sale | −3,000 | $34.66 | $104K | 0 |
| 2018-07-17 | Myer Vickesh Chief Technology Officer | Option exercise | +4,000 | $0.65 | $3K | 4,000 |
| 2018-07-17 | Myer Vickesh Chief Technology Officer | Sale | −4,000 | $36.50 | $146K | 0 |
| 2018-07-17 | Myer Vickesh Chief Technology Officer | Option exercise · Stock Option (right to buy) | −7,000 | 97,307 | ||
| 2018-07-02 | Bosley Katrine President and CEO | Sale | −3,000 | $36.00 | $108K | 1,290,632 |
| 2018-07-02 | Bosley Katrine President and CEO | Sale | −5,333 | $36.46 | $194K | 1,285,299 |
| 2018-06-19 | Myer Vickesh Chief Technology Officer | Option exercise | +7,000 | $11.21 | $78K | 7,000 |
| 2018-06-19 | Myer Vickesh Chief Technology Officer | Sale | −7,000 | $38.39 | $269K | 0 |
| 2018-06-19 | Myer Vickesh Chief Technology Officer | Option exercise · Stock Option (right to buy) | −7,000 | 83,897 | ||
| 2018-06-18 | Myer Vickesh Chief Technology Officer | Option exercise | +4,300 | $0.65 | $3K | 4,300 |
| 2018-06-18 | Myer Vickesh Chief Technology Officer | Sale | −4,300 | $37.75 | $162K | 0 |
| 2018-06-18 | Myer Vickesh Chief Technology Officer | Option exercise | +2,700 | $0.65 | $2K | 2,700 |
| 2018-06-18 | Myer Vickesh Chief Technology Officer | Sale | −2,700 | $38.71 | $105K | 0 |
| 2018-06-18 | Myer Vickesh Chief Technology Officer | Option exercise · Stock Option (right to buy) | −7,000 | 104,307 | ||
| 2018-06-15 | Nikolic Boris Director | Grant or award · Stock Option (right to buy) | +11,538 | 11,538 | ||
| 2018-06-15 | Vaishnaw Akshay Director | Grant or award · Stock Option (right to buy) | +11,538 | 11,538 |
Page 18 of 30 · 588 trades